Cantel Medical Corp.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Cantel Medical Corp. generated cash of $136,857,000, which is more than the previous year. Cash used in financing activities reached the amount of $852,670,000 last year. Net change in cash is therefore $233,336,000.
Cash Flow
| 2011 | 28.19M | -35.72M | 2.97M |
|---|---|---|---|
| 2012 | 50.58M | -103.11M | 64.50M |
| 2013 | 51.49M | -52.04M | 4.42M |
| 2014 | 64.27M | -47.43M | -18.94M |
| 2015 | 59.07M | -52.29M | -6.10M |
| 2016 | 80.26M | -112.98M | 29.94M |
| 2017 | 108.19M | -97.06M | -2.75M |
| 2018 | 125.91M | -125.18M | 57.13M |
| 2019 | 66.93M | -133.02M | 14.70M |
| 2020 | 136.85M | -752.85M | 852.67M |
CMD Cash Flow Statement (2011 – 2020)
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 44.53M | 94.09M | 36.58M | 28.36M | 31.72M | 31.78M | 34.07M | 30.18M | 18.41M | 22.61M |
Operating activities | ||||||||||
Net income | 13.70M | 55.04M | 91.04M | 71.37M | 59.95M | 47.95M | 43.26M | 39.23M | 31.33M | 20.42M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 74.34M | 42.35M | 34.83M | 33.45M | 25.08M | 23.95M | 18.88M | 17.26M | 15.92M | 12.44M |
Stock-based compensation expense | 12.07M | 15.56M | 9.61M | 8.84M | 8.36M | 5.86M | 5.40M | 3.73M | 3.84M | 3.35M |
| Deferred income tax benefit | 12.07M | 15.56M | 9.61M | 8.84M | 8.36M | 5.86M | 5.40M | 3.73M | 3.84M | 3.35M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 25.74M | -23.04M | -3.7M | -12.86M | -12.72M | -3.90M | -6.14M | -2.44M | 2.30M | -13.44M |
Inventories | 12.36M | -28.71M | -3.78M | 887K | -15.55M | -10.07M | -2.65M | -5.26M | -2.22M | -2.03M |
Accounts payable | -1.71M | 13.32M | 10.61M | 7.03M | 17.65M | -3.34M | 6.42M | -1.56M | 0 | 0 |
Cash generated by operating activities | 136.85M | 66.93M | 125.91M | 108.19M | 80.26M | 59.07M | 64.27M | 51.49M | 50.58M | 28.19M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -33.79M | -95.43M | -37.69M | -27.06M | -18.88M | -12.76M | -13.54M | -6.74M | 0 | 0 |
Acquisitions Net | -721.35M | -38M | -87M | -70M | -95M | -40M | -34M | -45M | -98M | -30M |
Cash generated by investing activities | -752.85M | -133.02M | -125.18M | -97.06M | -112.98M | -52.29M | -47.43M | -52.04M | -103.11M | -35.72M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Payments for dividends | -4.47M | -8.35M | -7.09M | -5.84M | -5.00M | -4.15M | -3.72M | -3.01M | -2.52M | -2.06M |
Repurchases of common stock | -4.06M | -4.74M | -7.07M | -6.91M | -3.73M | -3.72M | -4.43M | -2.25M | -1.90M | -1.29M |
Repayments of term debt | -76.92M | 0 | -208.3M | 0 | -59M | 0 | -42.5M | -40M | -32M | -25M |
Cash used in financing activities | 852.67M | 14.70M | 57.13M | -2.75M | 29.94M | -6.10M | -18.94M | 4.42M | 64.50M | 2.97M |
Net Change In Cash | 233.33M | -49.56M | 57.51M | 8.21M | -3.35M | -61K | -2.29M | 3.89M | 11.77M | -4.20M |
Cash at end of period | 277.87M | 44.53M | 94.09M | 36.58M | 28.36M | 31.72M | 31.78M | 34.07M | 30.18M | 18.41M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |